Randomized Placebo-Controlled Crossover Trial of Suvorexant for Sleep in Children With Autism
Latest Information Update: 19 Feb 2025
At a glance
- Drugs Suvorexant (Primary)
- Indications Pervasive child development disorders
- Focus Therapeutic Use
Most Recent Events
- 12 Feb 2025 Planned End Date changed from 28 Feb 2027 to 28 Feb 2028.
- 12 Feb 2025 Planned primary completion date changed from 28 Feb 2027 to 28 Feb 2028.
- 26 Jul 2023 Planned End Date changed from 30 Jun 2027 to 28 Feb 2027.